SAN FRANCISCO — Transcatheter mitral valve repair (TMVR) with the MitraClip (Abbott) is a reasonably cost-effective strategy but not cost-saving, even if the device were free, an economic analysis of ...

Hospitals that perform a larger number of transcatheter mitral valve repairs (TMVRs) with the MitraClip (Abbott) have significantly better procedural success, as well as shorter procedural times and ...

Global health care major Abbott Laboratories ABT recently presented one-year positive outcomes from the study of the MitraClip system in transcatheter mitral valve repair (TMVR) procedures in the U.S.

Experts at the annual meeting of the American College of Cardiology in San Diego said postmarket registry data collected on Abbott's ($ABT) MitraClip to enable less ...

ABBOTT PARK, Ill., Jan. 20, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the U.S. Centers for Medicare & Medicaid Services (CMS) revised its National Coverage Determination (NCD) to ...

The Centers for Medicare & Medicaid Services (CMS) is seeking input on whether to expand coverage for transcatheter mitral valve repair (TMVR) to include patients with significant symptomatic ...

NEW ORLEANS — To much acclaim, the COAPT trial demonstrated that use of the MitraClip (Abbott) in a very sick population with symptomatic (heart failure (HF) and secondary mitral regurgitation (MR) ...

The "US Market Report for Transcatheter Mitral Valve Repair Devices 2018 - MedCore" report has been added to Research and Markets' offering. Abbott Laboratories' MitraClip is the only TMVR device ...

Clinicians should use echocardiography, an ultrasound that shows the heart's structure and function, when determining whether patients with heart failure and a leaking heart valve are likely to ...

- New national reimbursement enables access to transcatheter mitral valve repair procedures with MitraClip for people with secondary mitral regurgitation, significantly expanding the eligible patient ...